168 related articles for article (PubMed ID: 35341799)
1. Obstructive Sleep Apnea in Coronary Artery Disease.
Ooi EL; Rajendran S
Curr Probl Cardiol; 2023 Aug; 48(8):101178. PubMed ID: 35341799
[TBL] [Abstract][Full Text] [Related]
2. Obstructive sleep apnea and self-reported functional impairment in revascularized patients with coronary artery disease in the RICCADSA trial.
Baniak LM; Chasens ER; Luyster FS; Strollo PJ; Thunström E; Peker Y
Sleep Breath; 2018 Dec; 22(4):1169-1177. PubMed ID: 30324547
[TBL] [Abstract][Full Text] [Related]
3. Effect of continuous positive airway pressure on long-term cardiovascular outcomes in patients with coronary artery disease and obstructive sleep apnea: a systematic review and meta-analysis.
Wang X; Zhang Y; Dong Z; Fan J; Nie S; Wei Y
Respir Res; 2018 Apr; 19(1):61. PubMed ID: 29636058
[TBL] [Abstract][Full Text] [Related]
4. Long-term use of continuous positive airway pressure therapy in coronary artery disease patients with nonsleepy obstructive sleep apnea.
Luyster FS; Strollo PJ; Thunström E; Peker Y
Clin Cardiol; 2017 Dec; 40(12):1297-1302. PubMed ID: 29243273
[TBL] [Abstract][Full Text] [Related]
5. Markers of Myocardial Ischemia in Patients With Coronary Artery Disease and Obstructive Sleep Apnea: Effect of Continuous Positive Airway Pressure Therapy.
Valo M; Wons A; Moeller A; Teupe C
Clin Cardiol; 2015 Aug; 38(8):462-8. PubMed ID: 26175232
[TBL] [Abstract][Full Text] [Related]
6. Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial.
Peker Y; Glantz H; Eulenburg C; Wegscheider K; Herlitz J; Thunström E
Am J Respir Crit Care Med; 2016 Sep; 194(5):613-20. PubMed ID: 26914592
[TBL] [Abstract][Full Text] [Related]
7. CPAP Does Not Reduce Inflammatory Biomarkers in Patients With Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea: A Randomized Controlled Trial.
Thunström E; Glantz H; Yucel-Lindberg T; Lindberg K; Saygin M; Peker Y
Sleep; 2017 Nov; 40(11):. PubMed ID: 29029237
[TBL] [Abstract][Full Text] [Related]
8. Association between obstructive sleep apnea and cardiovascular diseases.
Li YE; Ren J
Acta Biochim Biophys Sin (Shanghai); 2022 Jul; 54(7):882-892. PubMed ID: 35838200
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and predictors of obstructive sleep apnea in a revascularized coronary artery disease cohort.
Glantz H; Thunström E; Herlitz J; Cederin B; Nasic S; Ejdebäck J; Peker Y
Ann Am Thorac Soc; 2013 Aug; 10(4):350-6. PubMed ID: 23952854
[TBL] [Abstract][Full Text] [Related]
10. Pathway-Specific Polygenic Risk Scores Identify Obstructive Sleep Apnea-Related Pathways Differentially Moderating Genetic Susceptibility to Coronary Artery Disease.
Goodman MO; Cade BE; Shah NA; Huang T; Dashti HS; Saxena R; Rutter MK; Libby P; Sofer T; Redline S
Circ Genom Precis Med; 2022 Oct; 15(5):e003535. PubMed ID: 36170352
[TBL] [Abstract][Full Text] [Related]
11. Physiological Traits and Adherence to Sleep Apnea Therapy in Individuals with Coronary Artery Disease.
Zinchuk AV; Chu JH; Liang J; Celik Y; Op de Beeck S; Redeker NS; Wellman A; Yaggi HK; Peker Y; Sands SA
Am J Respir Crit Care Med; 2021 Sep; 204(6):703-712. PubMed ID: 34156917
[No Abstract] [Full Text] [Related]
12. Does continuous positive airway pressure therapy benefit patients with coronary artery disease and obstructive sleep apnea? A systematic review and meta-analysis.
Chen Y; Chen Y; Wen F; He Z; Niu W; Ren C; Li N; Wang Q; Ren Y; Liang C
Clin Cardiol; 2021 Aug; 44(8):1041-1049. PubMed ID: 34145595
[TBL] [Abstract][Full Text] [Related]
13. Continuous Positive Airway Pressure Treatment and Depression in Adults with Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea. A Secondary Analysis of the RICCADSA Trial.
Balcan B; Thunström E; Strollo PJ; Peker Y
Ann Am Thorac Soc; 2019 Jan; 16(1):62-70. PubMed ID: 30130421
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the Randomized Intervention with CPAP in Coronary Artery Disease and Sleep Apnoea--RICCADSA trial.
Peker Y; Glantz H; Thunström E; Kallryd A; Herlitz J; Ejdebäck J
Scand Cardiovasc J; 2009 Feb; 43(1):24-31. PubMed ID: 18663661
[TBL] [Abstract][Full Text] [Related]
15. Severity of obstructive sleep apnea and extension of coronary artery disease.
Rivera-Pérez SJ; Martinez D; Araujo GN; Goncalves SC; Lazzaretti LK; Wainstein RV; Wainstein MV; Ribeiro JP
Sleep Breath; 2019 Sep; 23(3):747-752. PubMed ID: 30552556
[TBL] [Abstract][Full Text] [Related]
16. Vascular responses to hypoxia are not impaired in obstructive sleep apnoea patients free of overt cardiovascular disease.
Beaudin AE; Hanly PJ; Raneri JK; Sajobi TT; Anderson TJ; Poulin MJ
Exp Physiol; 2019 Apr; 104(4):580-600. PubMed ID: 30697840
[TBL] [Abstract][Full Text] [Related]
17. Effect of CPAP on diastolic function in coronary artery disease patients with nonsleepy obstructive sleep apnea: A randomized controlled trial.
Glantz H; Johansson MC; Thunström E; Guron CW; Uzel H; Saygin M; Herlitz J; Peker Y
Int J Cardiol; 2017 Aug; 241():12-18. PubMed ID: 28408103
[TBL] [Abstract][Full Text] [Related]
18. Obstructive sleep apnea and cardiovascular disease.
Parish JM; Somers VK
Mayo Clin Proc; 2004 Aug; 79(8):1036-46. PubMed ID: 15301332
[TBL] [Abstract][Full Text] [Related]
19. Outcomes in coronary artery disease patients with sleepy obstructive sleep apnoea on CPAP.
Peker Y; Thunström E; Glantz H; Wegscheider K; Eulenburg C
Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29217597
[TBL] [Abstract][Full Text] [Related]
20. Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.
Arnaud C; Dematteis M; Pepin JL; Baguet JP; Lévy P
Semin Immunopathol; 2009 Jun; 31(1):113-25. PubMed ID: 19404644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
